Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | The importance of proteomics in myeloma and how this may be implemented in clinical practice

Arun Wiita, MD, PhD, University of California, San Francisco, CA, discusses how characterizing the myeloma cell surface proteome for different patient populations can lead to the identification of novel immunotherapeutic targets and markers of resistance in myeloma. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Research funding: Roche/Genentech